Traffic:
10E
10W
15N
15S
57N
57S
60E
60W
210E
210W
This Site
Web Search
powered by
YAHOO! SEARCH
Subscriber Services
|
Home Delivery
|
e-Edition
|
Alerts
|
RSS
Home
News
Ontario
Rancho Cucamonga
Pomona
Upland
Claremont
Montclair
Chino Valley
California
Crime & Public Safety
Elections
Education
S.B. County Watch
Upland Watch
I.E.: Medicare Testing Ground
Sports
Buy Event Tickets Now
Golf - Tee Times and Courses
Preps
Reign Hockey
Rancho Cucamonga Quakes
Local Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Ducks
Soccer
Motor Sports
Horse Racing
Live Odds
Business
Autos
Real Estate News
Technology
Opinions
Editorial
Letters
Columnists
Blogs
LA.COM
Buy Tickets
Movies
TV
Music
Shopping & Beauty
Recreation
Neighborhood
Arts
Living
Dining
Find A Restaurant
Lottery
Horoscopes
Travel
Trevor's Travels
Health
Crossword Puzzle
Local Casinos
Foothills Magazine
Info
Subscribe For Home Delivery
Contact Us
RSS
Podcast
Subscriber Services
Place An Ad
NIE
Classified
Place an Ad
Homes
Jobs
Auto
Search autos
Buy/Sell a car
Research/Financing a car
Find a dealer
Shopping
This week's ads
Obits
Directories
Local Business
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aligos Therapeutics Inc
(NQ:
ALGS
)
7.250
+0.040 (+0.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aligos Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Earnings Scheduled For March 12, 2024
March 12, 2024
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.
Via
Benzinga
Aligos Therapeutics Earnings Preview
March 11, 2024
Via
Benzinga
Earnings Outlook For Aligos Therapeutics
November 01, 2023
Via
Benzinga
Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024
March 05, 2024
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024
February 26, 2024
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics to Host KOL Event to Discuss Phase 2a HERALD Study of ALG-055009 in MASH on March 7, 2024
February 20, 2024
Event to feature KOL perspective on emerging MASH therapies
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments
February 13, 2024
From
Aligos Therapeutics
Via
GlobeNewswire
Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
December 08, 2023
Shares of Hello Group Inc. (NASDAQ: MOMO) jumped in pre-market trading after reporting results for the third quarter.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 07, 2023
Via
Benzinga
Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)
December 07, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference
November 20, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Why Is Tharimmune (THAR) Stock Down 8% Today?
November 20, 2023
Tharimmune stock is falling after the company announced a reverse stock split for THAR shares that goes into effect later today.
Via
InvestorPlace
Why Is Aligos Therapeutics (ALGS) Stock Down 5% Today?
November 20, 2023
Aligos Therapeutics stock is falling alongside news of a secondary offering for ALGS that it won't see any proceeds of the sales from.
Via
InvestorPlace
Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket
November 20, 2023
Shares of Applied UV, Inc. (NASDAQ: AUVI) shares jumped in pre-market trading after the company reported third-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 20, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 20, 2023
It's time to start the week with a breakdown of the biggest pre-market stock movers traders need to watch on Monday morning!
Via
InvestorPlace
Aligos Therapeutics Presents Clinical and Nonclinical Data at the AASLD Liver Meeting® 2023 Demonstrating that ALG-055009 has a Favorable Risk-Benefit Profile
November 13, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics Presents Positive Data at the AASLD Liver Meeting® 2023 Demonstrating that Treatment with ALG-000184 (CAM-E) Results in Significant Multi-log Reductions in Hepatitis B Antigens (HBsAg, HBcrAg and HBeAg)
November 10, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics to Present Multiple Posters at AASLD’s The Liver Meeting® 2023, Highlighting Progress for Its Clinical Stage Portfolio, including Lead THR-β Agonist for the Treatment of NASH, ALG-055009; ALG-000184, the Company’s Lead CAM-E Molecule,
November 07, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data
November 03, 2023
November 16 Event to feature KOL perspective on Emerging HBV Therapies
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results
November 02, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
October 27, 2023
Via
Benzinga
Aligos Therapeutics to Announce 3rd Quarter Results on November 2, 2023
October 26, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics To Present Late Breaking Poster on ALG-000184, its CAM-E Drug Candidate, at The Liver Meeting® 2023
October 25, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Why Aligos Therapeutics (ALGS) Stock Is Nosediving
October 23, 2023
Aligos Therapeutics Inc (NASDAQ: ALGS) shares are trading lower by 15.8% to $0.64 Monday afternoon after the company announced $92 million in private placement financing
Via
Benzinga
Aligos Therapeutics Announces $92 Million Private Placement Financing
October 23, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics Announces Award of an $8.5 Million NIAID Contract to Advance Development of Best-In-Class Pan-Coronavirus Protease Inhibitor, ALG-097558
October 03, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics Announces IND Clearance for NASH lead, ALG-055009
September 21, 2023
- Phase 2a NASH protocol on track to be submitted to the IND in Q4 2023, enrollment expected to begin in Q1 2024
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2023 Financial Results
August 03, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics to Announce Second Quarter Results on August 03, 2023
July 27, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Privacy Policy
|
Terms of Use
|
MNG Corporate Site Map
|
Copyright